From: Anti-fibrotic effect of a selective estrogen receptor modulator in systemic sclerosis
Target name | Direction | Primer sequence | Size |
---|---|---|---|
hOCT4 | Forward | ACCCCTGGTGCCGTGAA | 190 |
 | Reverse | GGCTGAATACCTTCCCAAATA |  |
hCD44 | Forward | AAGGTGGAGCAAACACAACC | 151 |
 | Reverse | AGCTTTTTCTTCTGCCCACA |  |
hCOL1A1 | Forward | CCCCTGGAAAGAATGGAGATG | 148 |
 | Reverse | TCCAAACCACTGAAACCTCTG |  |
hCOL1A2 | Forward | GGATGAGGAGACTGGCAACC | 77 |
 | Reverse | TGCCCTCAGCAACAAGTTCA |  |
hCOL3A1 | Forward | CGCCCTCCTAATGGTCAAGG | 161 |
 | Reverse | TTCTGAGGACCAGTAGGGCA |  |
hVimentin | Forward | GAGAACTTTGCCGTTGAAGC | 170 |
 | Reverse | TCCAGCAGCTTCCTGTAGGT |  |
hPAX6 | Forward | GTCCATCTTTGCTTGGGAAA | 110 |
 | Reverse | TAGCCAGGTTGCGAAGAACT |  |
hSOX1 | Forward | CACAACTCGGAGATCAGCAA | 133 |
 | Reverse | GGTACTTGTAATCCGGGTGC |  |
hNp63 | Forward | GGAAAACAATGCCCAGACTC | 294 |
 | Reverse | GTGGAATACGTCCAGGTGGC |  |
hKRT5 | Forward | ACCGTTCCTGGGTAACAGAGCCAC | 198 |
 | Reverse | GCGGGAGACAGACGGGGTGATG |  |
hKRT14 | Forward | GCAGTCATCCAGAGATGTGACC | 181 |
 | Reverse | GGGATCTTCCAGTGGGATCT |  |
hGAPDH | Forward | ACCCACTCCTCCACCTTTGA | 110 |
 | Reverse | CTGTTGCTGTAGCCAAATTCGT |  |
mCOL1A1 | Forward | GCAACAGTCGCTTCACCTACA | 138 |
 | Reverse | CAATGTCCAAGGGAGCCACAT |  |
mCOL3A1 | Forward | TGAGCGTGGCTATTCCTTCGT | 76 |
 | Reverse | GCCGTGGCCATCTCATTTTCAA |  |
mACTA2 | Forward | GTTCTAGAGGATGGCTGTACTA | 108 |
 | Reverse | TTGCCTTGCGTGTTTGATATTC |  |
mGAPDH | Forward | ACCCCAGCAAGGACACTGAGCAAG | 92 |
 | Reverse | TGGGGGTCTGGGATGGAAATTGTG |  |